Prophylactic Antibiotic Treatment for Laparoscopic Inguinal Hernia Mesh Repair: Necessary or Not?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02083939|
Recruitment Status : Terminated (Recruitment failed)
First Posted : March 11, 2014
Last Update Posted : June 4, 2020
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||5 participants|
|Official Title:||Prophylactic Antibiotic Treatment for Laparoscopic Inguinal Hernia Mesh Repair: Necessary or Not?|
|Study Start Date :||March 2014|
|Actual Primary Completion Date :||September 17, 2019|
|Actual Study Completion Date :||September 17, 2019|
This cohort will receive antibiotic prophylaxis prior to the hernia repair
No Antibiotic Prophylaxis
This cohort will not receive antibiotic prophylaxis prior to the surgery
- Incidence of surgical site infection [ Time Frame: One year post-operation ]The investigators will interview the patient at one week, at one month, and at one year post-operation and assess for any signs of infection around the location of hernia repair.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02083939
|Sheba Medical Center|
|Tel Hashomer, Israel|
|Principal Investigator:||Danny Rosin, MD||Sheba Medical Center|